Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome.

Maruyama K, McGuire JJ, Kagota S.

Biol Pharm Bull. 2017;40(12):2039-2044. doi: 10.1248/bpb.b17-00343.

2.

Intrauterine growth-restricted Yucatan miniature pigs experience early catch-up growth, leading to greater adiposity and impaired lipid metabolism as young adults.

Myrie SB, McKnight LL, King JC, McGuire JJ, Van Vliet BN, Cheema SK, Bertolo RF.

Appl Physiol Nutr Metab. 2017 Dec;42(12):1322-1329. doi: 10.1139/apnm-2017-0311. Epub 2017 Aug 16.

PMID:
28813611
3.

Time-Dependent Differences in the Influence of Perivascular Adipose Tissue on Vasomotor Functions in Metabolic Syndrome.

Kagota S, Iwata S, Maruyama K, McGuire JJ, Shinozuka K.

Metab Syndr Relat Disord. 2017 Jun;15(5):233-239. doi: 10.1089/met.2016.0146. Epub 2017 Mar 30.

PMID:
28358621
4.

Cardiac expression of ryanodine receptor subtype 3; a strategic component in the intracellular Ca2+ release system of Purkinje fibers in large mammalian heart.

Daniels RE, Haq KT, Miller LS, Chia EW, Miura M, Sorrentino V, McGuire JJ, Stuyvers BD.

J Mol Cell Cardiol. 2017 Mar;104:31-42. doi: 10.1016/j.yjmcc.2017.01.011. Epub 2017 Jan 20.

PMID:
28111173
5.

Age-related changes to vascular protease-activated receptor 2 in metabolic syndrome: a relationship between oxidative stress, receptor expression, and endothelium-dependent vasodilation.

Maruyama K, Kagota S, McGuire JJ, Wakuda H, Yoshikawa N, Nakamura K, Shinozuka K.

Can J Physiol Pharmacol. 2017 Apr;95(4):356-364. doi: 10.1139/cjpp-2016-0298. Epub 2016 Oct 19.

PMID:
28103056
6.

Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.

Kagota S, Maruyama K, McGuire JJ.

Biomed Res Int. 2016;2016:3130496. doi: 10.1155/2016/3130496. Epub 2016 Feb 23. Review.

7.

[Role/function of protease-activated receptor 2 on vascular endothelium in metabolic syndrome].

Maruyama K, McGuire JJ, Shinozuka K, Kagota S.

Nihon Yakurigaku Zasshi. 2016 Mar;147(3):135-8. doi: 10.1254/fpj.147.135. Japanese. No abstract available.

PMID:
26960771
8.

Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.

Maruyama K, Kagota S, McGuire JJ, Wakuda H, Yoshikawa N, Nakamura K, Shinozuka K.

J Vasc Res. 2015;52(4):232-43. doi: 10.1159/000442415. Epub 2016 Jan 14.

PMID:
26760532
9.

Corrigendum: Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14608. Epub 2015 Jul 1. No abstract available.

PMID:
26131938
10.

Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Jun 4;522(7554):73-6. doi: 10.1038/nature14480. Erratum in: Nature. 2015 Sep 3;525(7567):144.

PMID:
26040890
11.

Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction.

Hennessey JC, Stuyvers BD, McGuire JJ.

Pharmacol Res Perspect. 2015 Mar;3(2):e00112. doi: 10.1002/prp2.112.

12.

Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndrome.

Kagota S, Maruyama K, Wakuda H, McGuire JJ, Yoshikawa N, Nakamura K, Shinozuka K.

Vascul Pharmacol. 2014 Oct;63(1):46-54. doi: 10.1016/j.vph.2014.06.005. Epub 2014 Aug 7.

PMID:
25109437
13.

Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.

Hughes KH, Wijekoon EP, Valcour JE, Chia EW, McGuire JJ.

Can J Physiol Pharmacol. 2013 Apr;91(4):295-305. doi: 10.1139/cjpp-2012-0266. Epub 2012 Dec 19.

14.

Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice.

Hennessey JC, McGuire JJ.

PLoS One. 2013;8(2):e55965. doi: 10.1371/journal.pone.0055965. Epub 2013 Feb 7.

15.
16.

Geophysics. A rogue earthquake off Sumatra.

McGuire JJ, Beroza GC.

Science. 2012 Jun 1;336(6085):1118-9. doi: 10.1126/science.1223983. Epub 2012 May 10. No abstract available.

PMID:
22582017
17.

Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice.

Chia E, Kagota S, Wijekoon EP, McGuire JJ.

BMC Pharmacol. 2011 Sep 28;11:10. doi: 10.1186/1471-2210-11-10.

18.

Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice.

Kagota S, Chia E, McGuire JJ.

Br J Pharmacol. 2011 Sep;164(2):358-71. doi: 10.1111/j.1476-5381.2011.01356.x.

19.
20.

Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats.

Smeda JS, McGuire JJ, Daneshtalab N.

Peptides. 2010 Feb;31(2):227-37. doi: 10.1016/j.peptides.2009.11.026. Epub 2009 Nov 30.

PMID:
19954757

Supplemental Content

Loading ...
Support Center